Alvotech and Teva Pharmaceuticals announced that the U.S. FDA has approved a new presentation of SELARSDI ... aligning it ...

As most advisors are well aware, high stock prices have pushed down the market’s dividend yield. Barron’s ran a screen for ...

Key multiple sclerosis companies such as Mapi Pharma, Novartis, Immunic, Biocad, Apimeds, Genentech (Roche), AB Science, Celltrion, Clene Nanomedicine, InnoCare Pharma, Oryzon Genomics, GeNeuro SA, ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

NEW YORK, Nov. 12, 2024 /PRNewswire/ -- According to a new comprehensive ... The botulinum toxin market is segmented on the basis of product, application, and end user. The report runs an in-depth ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

Bristol-Myers Squibb (BMY) stock was upgraded by Leerink Partners based on a potential sales boost for its schizophrenia ...

NK cell therapy is gaining momentum as a promising solution to unmet medical needs in cancer treatment, offering safer, tar ...

Gain insight on Rigel Pharmaceuticals, AbbVie and more in the latest Market Talks covering the Health Care sector.